Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • older patient with a doctor at their house

    Persistent mitral regurgitation after TAVR more common among women than men

    The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

  • Heart attack patients treated at for-profit hospitals more likely to be readmitted

    Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.

  • A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

    High-quality heart failure care is easy to find for many Americans—but care gaps remain

    The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.

  • obesity semaglutide tirzepatide GLP-1 drugs weight loss

    Semaglutide is improving the heart health of millions—but how? Experts are stumped

    “Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

  • artificial intelligence AI heart cardiology

    AI uses routine CT images to evaluate cardiovascular risk

    Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.

Thumbnail

Edwards gains CE mark for first transcatheter tricuspid treatment

Edwards Lifesciences has received CE mark approval for its Cardioband Tricuspid Valve Reconstruction System, making it the first commercially available transcatheter therapy to treat tricuspid valve heart disease.

Thumbnail

Cleveland Clinic's Cremer on cardiac imaging in cardiovascular oncology

At this year's "Nuclear Cardiology Today: Best Practices for Today, Innovation for Tomorrow" conference in Rosemont, Illinois, sponsored by the American Society of Nuclear Cardiology (ASNC), Paul Cremer, MD, discussed the role of cardiac imaging in cardio-oncology.

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.

ASNC Releases Dose-Reduction Guidelines for Nuclear Cardiology

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …202
    • Page 203
    • Page 204
    • Page 205
    • Page 206
    • Page 207
    • Page 208
    • Page 209
    • Current page 210
Displaying 1673 - 1678 of 1678
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme